Influence of noninvasive cardiovascular imaging in primary prevention: Systematic review and meta-analysis of randomized trials

Archives of Internal Medicine

Volumn 171, Issue 11, 2011, Pages 977-982

  Hackam, Daniel G ^a   Shojania, Kaveh G ^a   Spence, J David ^b   Alter, David A ^c   Beanlands, Rob S ^d   Dresser, George K ^a   Goela, Aashish ^a   Davies, Alun H ^e   Badano, Luigi P ^f   Poldermans, Don ^g   Boersma, Eric ^h   Njike, Valentine Y ^h,i  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^e CHARING CROSS HOSPITAL   (United Kingdom)

^f UNIVERSITY OF PADOVA   (Italy)

^g Vascular Surgery   (Netherlands)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ Yale Griffin Prevention Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ANGIOGRAPHY; ARTERIAL ULTRASONOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; DIAGNOSTIC IMAGING; DIET; EXERCISE; EXERCISE ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HUMAN; LIFESTYLE MODIFICATION; META ANALYSIS; NONINVASIVE CARDIOVASCULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MYOCARDIAL PERFUSION IMAGING; PHYSICAL ACTIVITY; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SCINTIANGIOGRAPHY; SMOKING CESSATION; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; HUMANS; LIFE STYLE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 79959309723     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.69     Document Type: Article

References (21)

1. Bhatt DL, Steg PG, Ohman EM, et al; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180-189.
2. Schwamm L, Fayad P, Acker JE III, et al. Translating evidence into practice: a decade of efforts by the American Heart Association/American Stroke Association to reduce death and disability due to stroke: a presidential advisory from the American Heart Association/American Stroke Association. Stroke. 2010;41(5):1051-1065.
3. Redberg RF, Benjamin EJ, Bittner V, et al; American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Preventive Cardiovascular Nurses Association. AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation. 2009; 120(13):1296-1336.
4. Smith SC, Allen J, Blair SN, et al; AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006; 113(19):2363-2372.
5. Summary E. Executive summary: Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S4-S10.
6. Wijeysundera DN, Beattie WS, Austin PC, Hux JE, Laupacis A. Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study. BMJ. 2010;340: b5526.
7. Alter DA, Stukel TA, Newman A. Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare. Circulation. 2006; 113(3):380-387.
8. Higgins JPT, Altman DG; Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Assessing risk of bias in included studies. In: Hig-gins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley-Blackwell; 2008:187-242.
9. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36(5):936-942.
10. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21 (11):1539-1558.
11. Deeks JJ, Higgins JPT, Altman DG; Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ: Wiley-Blackwell; 2008: 243-296.
12. Bovet P, Perret F, Cornuz J, Quilindo J, Paccaud F. Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques. Prev Med. 2002;34(2):215-220.
13. Lederman J, Ballard J, Njike VY, Margolies L, Katz DL. Information given to postmenopausal women on coronary computed tomography may influence cardiac risk reduction efforts. J Clin Epidemiol. 2007;60(4):389-396.
14. Obuchowski NA, Holden D, Modic MT, et al. Total-body screening: preliminary results of a pilot randomized controlled trial. J Am Coll Radiol. 2007;4(9):604-611.
15. O'Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. JAMA. 2003;289(17):2215-2223.
16. Faglia E, Manuela M, Antonella Q, et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J. 2005;149(2):e1-e6.
17. Martina B, Nordmann A, Dieterle T, et al. Impact of baseline echocardiography on treatment outcome in primary care patients with newly detected arterial hypertension: a randomized trial. Am J Hypertens. 2006;19(11):1150-1155.
18. Young LH, Wackers FJT, Chyun DA, et al; DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301(15): 1547-1555.
19. Bovet P, Perret F, Shamlaye C, Darioli R, Pac-caud F. The Seychelles Heart Study II: methods and basic findings. Seychelles Med Dent J. 2007; 5(1):8-24.
20. O'Malley PG, Taylor AJ, Gibbons RV, et al. Rationale and design of the Prospective Army Coronary Calcium (PACC) Study: utility of electron beam computed tomography as a screening test for coronary artery disease and as an intervention for risk factor modification among young, asymptomatic, active-duty United States Army Personnel. Am Heart J. 1999;137(5):932-941.
21. Wackers FJT, Young LH, Inzucchi SE, et al; Detection of Ischemia in Asymptomatic Diabetics Investigators. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27(8):1954-1961.